Journal article
Heterozygous SOD2 deletion impairs glucose-stimulated insulin secretion, but not insulin action, in high-fat-fed mice
Diabetes (New York, N.Y.), Vol.63(11), pp.3699-3710
11/2014
DOI: 10.2337/db13-1845
PMCID: PMC4207395
PMID: 24947366
Abstract
Elevated reactive oxygen species (ROS) are linked to insulin resistance and islet dysfunction. Manganese superoxide dismutase (SOD2) is a primary defense against mitochondrial oxidative stress. To test the hypothesis that heterozygous SOD2 deletion impairs glucose-stimulated insulin secretion (GSIS) and insulin action, wild-type (sod2(+/+)) and heterozygous knockout mice (sod2(+/-)) were fed a chow or high-fat (HF) diet, which accelerates ROS production. Hyperglycemic (HG) and hyperinsulinemic-euglycemic (HI) clamps were performed to assess GSIS and insulin action in vivo. GSIS during HG clamps was equal in chow-fed sod2(+/-) and sod2(+/+) but was markedly decreased in HF-fed sod2(+/-). Remarkably, this impairment was not paralleled by reduced HG glucose infusion rate (GIR). Decreased GSIS in HF-fed sod2(+/-) was associated with increased ROS, such as superoxide ion. Surprisingly, insulin action determined by HI clamps did not differ between sod2(+/-) and sod2(+/+) of either diet. Since insulin action was unaffected, we hypothesized that the unchanged HG GIR in HF-fed sod2(+/-) was due to increased glucose effectiveness. Increased GLUT-1, hexokinase II, and phospho-AMPK protein in muscle of HF-fed sod2(+/-) support this hypothesis. We conclude that heterozygous SOD2 deletion in mice, a model that mimics SOD2 changes observed in diabetic humans, impairs GSIS in HF-fed mice without affecting insulin action.
Details
- Title: Subtitle
- Heterozygous SOD2 deletion impairs glucose-stimulated insulin secretion, but not insulin action, in high-fat-fed mice
- Creators
- Li Kang - Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN Mouse Metabolic Phenotyping Center, Vanderbilt University, Nashville, TN Division of Cardiovascular and Diabetes Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, U.K. l.kang@dundee.ac.ukChunhua Dai - Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University, Nashville, TNMary E Lustig - Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TNJeffrey S Bonner - Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TNWesley H Mayes - Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TNShilpa Mokshagundam - Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TNFreyja D James - Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TNCourtney S Thompson - Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University, Nashville, TNChien-Te Lin - East Carolina Diabetes and Obesity Institute and Departments of Physiology and Kinesiology, East Carolina University, Greenville, NCChristopher G R Perry - East Carolina Diabetes and Obesity Institute and Departments of Physiology and Kinesiology, East Carolina University, Greenville, NCEthan J Anderson - East Carolina Diabetes and Obesity Institute and Departments of Physiology and Kinesiology, East Carolina University, Greenville, NCP Darrell Neufer - East Carolina Diabetes and Obesity Institute and Departments of Physiology and Kinesiology, East Carolina University, Greenville, NCDavid H Wasserman - Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN Mouse Metabolic Phenotyping Center, Vanderbilt University, Nashville, TNAlvin C Powers - Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, Vanderbilt University, Nashville, TN Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN
- Resource Type
- Journal article
- Publication Details
- Diabetes (New York, N.Y.), Vol.63(11), pp.3699-3710
- Publisher
- United States
- DOI
- 10.2337/db13-1845
- PMID
- 24947366
- PMCID
- PMC4207395
- ISSN
- 0012-1797
- eISSN
- 1939-327X
- Grant note
- R37 DK050277 / NIDDK NIH HHS R01 DK073488 / NIDDK NIH HHS R56 DK054902 / NIDDK NIH HHS DK-69603 / NIDDK NIH HHS P30 DK020593 / NIDDK NIH HHS DK-059637 / NIDDK NIH HHS DK-072473 / NIDDK NIH HHS P60 DK020593 / NIDDK NIH HHS DK-20593 / NIDDK NIH HHS U01 DK089538 / NIDDK NIH HHS R33 DK066636 / NIDDK NIH HHS DK-66636 / NIDDK NIH HHS R01 DK069603 / NIDDK NIH HHS DK-089572 / NIDDK NIH HHS R21 DK066636 / NIDDK NIH HHS U24 DK059637 / NIDDK NIH HHS DK-054902 / NIDDK NIH HHS DK-089538 / NIDDK NIH HHS I01 BX000666 / BLRD VA R01 DK054902 / NIDDK NIH HHS U01 DK072473 / NIDDK NIH HHS U01 DK089572 / NIDDK NIH HHS
- Language
- English
- Date published
- 11/2014
- Academic Unit
- Pharmaceutical Sciences and Experimental Therapeutics; Fraternal Order of Eagles Diabetes Research Center; Health and Human Physiology
- Record Identifier
- 9984065690502771
Metrics
27 Record Views